Cell-based therapy for prevention and reversal of myocardial remodeling

Vasileios Karantalis, Wayne Balkan, Ivonne H. Schulman, Konstantinos E. Hatzistergos, Joshua M. Hare

Research output: Contribution to journalArticle

Abstract

Although pharmacological and interventional advances have reduced the morbidity and mortality of ischemic heart disease, there is an ongoing need for novel therapeutic strategies that prevent or reverse progressive ventricular remodeling following myocardial infarction, the process that forms the substrate for ventricular failure. The development of cell-based therapy as a strategy to repair or regenerate injured tissue offers extraordinary promise for a powerful anti-remodeling therapy. In this regard, the field of cell therapy has made major advancements in the past decade. Accumulating data from preclinical studies have provided novel insights into stem cell engraftment, differentiation, and interactions with host cellular elements, as well as the effectiveness of various methods of cell delivery and accuracy of diverse imaging modalities to assess therapeutic efficacy. These findings have in turn guided rationally designed translational clinical investigations. Collectively, there is a growing understanding of the parameters that underlie successful cell-based approaches for improving heart structure and function in ischemic and other cardiomyopathies.

Original languageEnglish (US)
Pages (from-to)256-270
Number of pages15
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume303
Issue number3
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Ventricular Remodeling
Cardiomyopathies
Cell Communication
Myocardial Ischemia
Cell Differentiation
Stem Cells
Therapeutics
Myocardial Infarction
Pharmacology
Morbidity
Mortality

Keywords

  • Bone marrow cells
  • Heart failure
  • Mesenchymal stem cells
  • Myocardial infarction
  • Stem cells

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Cell-based therapy for prevention and reversal of myocardial remodeling. / Karantalis, Vasileios; Balkan, Wayne; Schulman, Ivonne H.; Hatzistergos, Konstantinos E.; Hare, Joshua M.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 303, No. 3, 01.08.2012, p. 256-270.

Research output: Contribution to journalArticle

Karantalis, Vasileios ; Balkan, Wayne ; Schulman, Ivonne H. ; Hatzistergos, Konstantinos E. ; Hare, Joshua M. / Cell-based therapy for prevention and reversal of myocardial remodeling. In: American Journal of Physiology - Heart and Circulatory Physiology. 2012 ; Vol. 303, No. 3. pp. 256-270.
@article{a0fa1cc33adb4b20b7e8686869084446,
title = "Cell-based therapy for prevention and reversal of myocardial remodeling",
abstract = "Although pharmacological and interventional advances have reduced the morbidity and mortality of ischemic heart disease, there is an ongoing need for novel therapeutic strategies that prevent or reverse progressive ventricular remodeling following myocardial infarction, the process that forms the substrate for ventricular failure. The development of cell-based therapy as a strategy to repair or regenerate injured tissue offers extraordinary promise for a powerful anti-remodeling therapy. In this regard, the field of cell therapy has made major advancements in the past decade. Accumulating data from preclinical studies have provided novel insights into stem cell engraftment, differentiation, and interactions with host cellular elements, as well as the effectiveness of various methods of cell delivery and accuracy of diverse imaging modalities to assess therapeutic efficacy. These findings have in turn guided rationally designed translational clinical investigations. Collectively, there is a growing understanding of the parameters that underlie successful cell-based approaches for improving heart structure and function in ischemic and other cardiomyopathies.",
keywords = "Bone marrow cells, Heart failure, Mesenchymal stem cells, Myocardial infarction, Stem cells",
author = "Vasileios Karantalis and Wayne Balkan and Schulman, {Ivonne H.} and Hatzistergos, {Konstantinos E.} and Hare, {Joshua M.}",
year = "2012",
month = "8",
day = "1",
doi = "10.1152/ajpheart.00221.2012",
language = "English (US)",
volume = "303",
pages = "256--270",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Cell-based therapy for prevention and reversal of myocardial remodeling

AU - Karantalis, Vasileios

AU - Balkan, Wayne

AU - Schulman, Ivonne H.

AU - Hatzistergos, Konstantinos E.

AU - Hare, Joshua M.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Although pharmacological and interventional advances have reduced the morbidity and mortality of ischemic heart disease, there is an ongoing need for novel therapeutic strategies that prevent or reverse progressive ventricular remodeling following myocardial infarction, the process that forms the substrate for ventricular failure. The development of cell-based therapy as a strategy to repair or regenerate injured tissue offers extraordinary promise for a powerful anti-remodeling therapy. In this regard, the field of cell therapy has made major advancements in the past decade. Accumulating data from preclinical studies have provided novel insights into stem cell engraftment, differentiation, and interactions with host cellular elements, as well as the effectiveness of various methods of cell delivery and accuracy of diverse imaging modalities to assess therapeutic efficacy. These findings have in turn guided rationally designed translational clinical investigations. Collectively, there is a growing understanding of the parameters that underlie successful cell-based approaches for improving heart structure and function in ischemic and other cardiomyopathies.

AB - Although pharmacological and interventional advances have reduced the morbidity and mortality of ischemic heart disease, there is an ongoing need for novel therapeutic strategies that prevent or reverse progressive ventricular remodeling following myocardial infarction, the process that forms the substrate for ventricular failure. The development of cell-based therapy as a strategy to repair or regenerate injured tissue offers extraordinary promise for a powerful anti-remodeling therapy. In this regard, the field of cell therapy has made major advancements in the past decade. Accumulating data from preclinical studies have provided novel insights into stem cell engraftment, differentiation, and interactions with host cellular elements, as well as the effectiveness of various methods of cell delivery and accuracy of diverse imaging modalities to assess therapeutic efficacy. These findings have in turn guided rationally designed translational clinical investigations. Collectively, there is a growing understanding of the parameters that underlie successful cell-based approaches for improving heart structure and function in ischemic and other cardiomyopathies.

KW - Bone marrow cells

KW - Heart failure

KW - Mesenchymal stem cells

KW - Myocardial infarction

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84864555025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864555025&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00221.2012

DO - 10.1152/ajpheart.00221.2012

M3 - Article

VL - 303

SP - 256

EP - 270

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 3

ER -